Citation: | ZHANG Mei, SHAN Ke-ming, XU Wei, LIN Fan-kai, CHEN Zhao, DENG Yu-lin. Establishment of in vitro human aging model and primary screening of aging peptide-biomarkers[J].JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2016, 25(2): 295-300.doi:10.15918/j.jbit1004-0579.201625.0219 |
[1] |
Bowen R L, Atwood C S. Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones[J]. Gerontology, 2004, 50:265-290.
|
[2] |
Kohn R R. Aging and age-related diseases:normal processes[M]. Relation between normal aging and disease. Johnson H A, ed. New York:Raven Press, 1985:1-44.
|
[3] |
Upton A C. Pathology[M]. The biology of aging. Finch C E, Hayflick L, eds. New York:Van Nostrand, 1977:513-535.
|
[4] |
Harman D. Aging:prospects for further increases in the functional life span[J]. Age, 1994, 17:119-146.
|
[5] |
Rockstein M, Sussman M L, Chesky J. Theoretical aspects of aging[M]. 2nd ed. New York:Academic Press, 1974.
|
[6] |
Hayflick L. Theories of biological aging[J]. Exp Gerontol, 1985, 20:145-159.
|
[7] |
Warner H R, Butler R N, Sprott R L, et al. Modern biological theories of aging[M]. New York:Raven Press, 1987.
|
[8] |
Medvedev Z A. An attempt at a rational classification of theories of aging[J]. Biol Rev Camb Philos Soc, 1990, 65:375-398.
|
[9] |
Holliday R. Understanding ageing[M]. New York:Cambridge University Press, 1995.
|
[10] |
Bjorksten J. The crosslinkage theory of aging[J]. J Am Geriatr Soc, 1968, 16:408-427.
|
[11] |
Walford R L. The immunologic theory of aging[M]. Copenhagen, Denmark:Munksgaard, 1969.
|
[12] |
Harman D. Free radical involvement in aging:Pathophysiology and therapeutic implications[J]. Drugs Aging, 1993, 3:60-80.
|
[13] |
Hayflick L. Origins of longevity[M]. Modern biological theories of aging. Warner H R, Butler R N, Sprott R L,et al., eds. New York:Raven Press, 1987:21-34.
|
[14] |
Kruk P A, Rampino N J, Bohr V A. DNA damage and repair in telomeres:relation to aging[J]. Proc Natl Acad Sci USA, 1995, 92:258-262.
|
[15] |
Hodge J E. Chemistry of browning in model systems[J]. J Agric Food Chem, 1953, 1:928-943.
|
[16] |
Ledl F, Schleicher E. New aspects of the maillard reaction in foods and in the human body[J]. Angew Chem Int Ed Engl, 1990, 29:565-594.
|
[17] |
Takedo A, Yasuda T, Miyata T, et al. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain[J]. Neurosci Lett, 1996, 221:17-20.
|
[18] |
Asif M, Egan J, Vasan S, et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness[J]. Proc Natl Acad Sci USA, 2000, 97:2809-2813.
|
[19] |
Lyles G A, Chalmers J. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery[J]. Biochem Pharmacol, 1992, 43:1409-1414.
|
[20] |
Yu P H, Deng Y L. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis:involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover[J]. Atherosclerosis, 1998, 140:357-363.
|
[21] |
Kazachkov M, Chen K, Babiy S, et al. Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination[J].J Pharmacol Exp Ther, 2007, 322:1201-1207.
|
[22] |
Castillo V, Lizcano J M, Visa J, et al. Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues:biochemical and immunohistological characterization[J]. Neurochem Int, 1998, 33:415-423.
|
[23] |
Zhang M, Shan K M, Xu W, et al. Quantification of CP4-EPSPS in genetically modified Nicotiana tabacum leaves by LC-MS/MS with
18O-labeling[J]. Journal of Beijing Institute of Technology, 2015,24(2):277-284.
|
[24] |
Fields R. The measurement of amino groups in proteins and peptides[J]. Biochem J, 1971, 124:581-590.
|
[25] |
Zhang M, Lv D H, Dai R J, et al. Establishment and optimization of peptide biomarker screening model in diabetes
in vitroby HPLC/ESI-TOF mass spectrometry[J]. Journal of Beijing Institute of Techonolgy, 2013, 22(4):563-568.
|